Impax Laboratories Inc (NASDAQ:IPXL)

49.98
Delayed Data
As of Apr 17
 -1.28 / -2.50%
Today’s Change
22.12
Today|||52-Week Range
52.10
+57.77%
Year-to-Date

Today’s Trading

Previous close51.26
Today’s open49.41
Day’s range49.11 - 50.24
Volume1,134,276
Average volume (3 months)647,423
Market cap$3.7B
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+12.49%
Earnings growth (next 5 years)+29.31%
Revenue growth (last year)+16.53%
P/E ratio61.5
Price/Sales3.62
Price/Book4.11

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-1.12-2.57%
ACADACADIA Pharmaceutica...-0.64-1.66%
HZNPHorizon Pharma PLC-0.15-0.50%
ASPXAuspex Pharmaceutica...+0.02+0.02%
Data as of 3:59pm ET, 04/17/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$0.17
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers